The Akt/mTOR Pathway and Estrogen Receptor Phosphorylations : a crosstalk with potential to predict tamoxifen resistance in breast cancer
Estrogen receptor α content is the primary breast cancer biomarker distinguishing the patients responsive from the non-responsive to endocrine treatments. Tamoxifen is an estrogen competitor with large potential to treat breast cancer patients and prolongs time to recurrence. Despite the estrogen re...
| Main Author: | |
|---|---|
| Format: | Doctoral Thesis |
| Language: | English |
| Published: |
Linköpings universitet, Avdelningen för kliniska vetenskaper
2013
|
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-100903 http://nbn-resolving.de/urn:isbn:978-91-7519-515-5 (print) |